Small-cap Immunocore has been a price leader within the biotech industry. Analysts have a “buy” rating on the stock and estimate that it will move 25% higher.
Small-cap Immunocore has been a price leader within the biotech industry. Analysts have a “buy” rating on the stock and estimate that it will move 25% higher.
Kate Stalter is a widely acclaimed financial author and investing expert for U.S. News & World Report.
Here, you’ll find videos on the stock market for beginners, as well as more seasoned investors.
Welcome to your successful, worry-free retirement! Today’s Baby Boomers risk running out of money in retirement, and I’m here to make sure that doesn’t happen to you.
© 2023 Kate Stalter. All rights reserved.